Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

The study created a new method to test drugs that affect hormone processing in skin.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.